Prof. Dr. ID: 68114
Carsten Bokemeyer
Publications
- 2013
Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab
Piessevaux, H., Buyse, M., Schlichting, M., Van Cutsem, E., Bokemeyer, C., Heeger, S. & Tejpar, S., 20.10.2013, In: J CLIN ONCOL. 31, 30, p. 3764-75 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma
Ben Batalla, I., Schultze, A., Wroblewski, M., Erdmann, R., Heuser, M., Waizenegger, J. S., Riecken, K., Binder, M., Schewe, D., Sawall, S., Witzke, V., Cubas Cordova, M., Janning, M., Wellbrock, J., Fehse, B., Hagel, C., Krauter, J., Ganser, A., Lorens, J. B., Fiedler, W., Carmeliet, P., Pantel, K., Bokemeyer, C. & Loges, S., 03.10.2013, In: BLOOD. 122, 14, p. 2443-52 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Active surveillance is the preferred approach to clinical stage I testicular cancer
Nichols, C. R., Roth, B., Albers, P., Einhorn, L. H., Foster, R., Daneshmand, S., Jewett, M., Warde, P., Sweeney, C. J., Beard, C., Powles, T., Tyldesley, S., So, A., Porter, C., Olgac, S., Fizazi, K., Hayes-Lattin, B., Grimison, P., Toner, G., Cathomas, R., Bokemeyer, C. & Kollmannsberger, C., 01.10.2013, In: J CLIN ONCOL. 31, 28, p. 3490-3 4 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Oldenburg, J., Fosså, S. D., Nuver, J., Heidenreich, A., Schmoll, H-J., Bokemeyer, C., Horwich, A., Beyer, J., Kataja, V. & ESMO Guidelines Committee, 01.10.2013, In: ANN ONCOL. 24 Suppl 6, p. vi125-32Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Anxiety and depression in caregivers of terminally ill cancer patients: impact on their perspective of the patients' symptom burden
Oechsle, K., Goerth, K., Bokemeyer, C. & Mehnert, A., 01.09.2013, In: J PALLIAT MED. 16, 9, p. 1095-101 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Impact of physiological BM CD10+CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML
Christopeit, M., Heiland, A., Binder, M., Zabelina, T., Ayuketang, F. A., Horn, C., Haferlach, T., Bokemeyer, C., Kröger, N. & Bacher, U., 01.09.2013, In: BONE MARROW TRANSPL. 48, 9, p. 1257-9 3 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research
Prolonging Survival Through a Personalized Approach in Metastatic Colorectal Cancer
Stein, A. & Bokemeyer, C., 09.2013, In: J OncoPathol. 1, 3, p. 31-41Research output: SCORING: Contribution to journal › SCORING: Journal article › Transfer › peer-review
Acute psychological stress increases peripheral blood CD3+CD56+ natural killer T cells in healthy men: possible implications for the development and treatment of allergic and autoimmune disorders
Atanackovic, D., Nowottne, U., Freier, E., Weber, C. S., Meyer, S., Bartels, K., Hildebrandt, Y., Cao, Y., Kröger, N-M., Brunner-Weinzierl, M. C., Bokemeyer, C. & Deter, H-C., 01.07.2013, In: STRESS. 16, 4, p. 421-8 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Symptom burden in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians
Oechsle, K., Görth, K., Bokemeyer, C. & Mehnert, A., 01.07.2013, In: SUPPORT CARE CANCER. 21, 7, p. 1955-62 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Spättoxizität und Survivorship bei Keimzelltumoren
Oechsle, K., Schilling, G., Oing, C. & Bokemeyer, C., 07.2013, In: ONKOLOGE. 19, 7, p. 573-581 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives
Berger, L. A., Riesenberg, H., Bokemeyer, C. & Atanackovic, D., 01.06.2013, In: LUNG CANCER. 80, 3, p. 242-8 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reducing the burden of bone metastases: current concepts and treatment options
von Moos, R., Sternberg, C., Body, J-J. & Bokemeyer, C., 01.06.2013, In: SUPPORT CARE CANCER. 21, 6, p. 1773-83 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer
Flammiger, A., Weisbach, L., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 01.04.2013, In: EUR J CANCER. 49, 6, p. 1273-9 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Modeling of treatment response to erythropoiesis-stimulating agents in older (age≥70years) and younger (age<70years) patients with cancer and anemia: findings from the Anemia Cancer Treatment study
Abraham, I., MacDonald, K., Tharmarajah, S., Bokemeyer, C., Ludwig, H., Soubeyran, P., Battistel, V. & Aapro, M., 01.04.2013, In: J GERIATR ONCOL. 4, 2, p. 196-201 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase
Langer, F., Spath, B., Fischer, C., Stolz, M., Ayuketang, F. A., Kröger, N-M., Bokemeyer, C. & Ruf, W., 21.03.2013, In: BLOOD. 121, 12, p. 2324-35 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Evaluation of BM cytomorphology after allo-SCT in patients with MDS
Christopeit, M., Ocheni, S., Haferlach, T., Miersch, K., Zabelina, T., Klyuchnikov, E., Binder, M., Ayuketang, F. A., Schafhausen, P., Zander, A. R., Bokemeyer, C., Kröger, N. & Bacher, U., 01.03.2013, In: BONE MARROW TRANSPL. 48, 3, p. 465-6 2 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research
Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer
Grob, T. J., Hoenig, T., Clauditz, T. S., Atanackovic, D., Koenig, A. M., Vashist, Y. K., Klose, H., Simon, R., Pantel, K., Izbicki, J. R., Bokemeyer, C., Sauter, G. & Wilczak, W., 01.03.2013, In: LUNG CANCER. 79, 3, p. 221-7 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Tumore des Urogenitaltrakts
Bokemeyer, C., Oechsle, K. & Oing, C., 27.01.2013, OnkoUpDate: Handbuch. Wiesbaden: med publico GmbH, 40 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors
Balabanov, S., Wilhelm, T., Venz, S., Amsberg, G., Scharf, C., Pospisil, H., Balabanov, M., Barett, C., Bokemeyer, C., Walther, R., Brümmendorf, T. H. & Schuppert, A., 01.01.2013, In: PLOS ONE. 8, 1, p. e53668Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway
Oliveira Ferrer, L., Wellbrock, J., Bartsch, U., Penas, E. M. M., Hauschild, J., Klokow, M., Bokemeyer, C., Fiedler, W. & Schuch, G., 01.01.2013, In: MOL CANCER. 12, 1, p. 144Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Late recurrence of a pineal germinoma 14 years after radiation and chemotherapy: a case report and review of the literature
Janjetovic, S., Bokemeyer, C., Fiedler, W., Frenzel, T., Calaminus, G. & Honecker, F., 01.01.2013, In: ONKOLOGIE. 36, 6, p. 371-3 3 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment
de Wit, M., Ortner, P., Lipp, H-P., Sehouli, J., Untch, M., Ruhnke, M., Mayer-Steinacker, R., Bokemeyer, C. & Jordan, K., 01.01.2013, In: ONKOLOGIE. 36, 3, p. 127-35 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Relevant bleeding diathesis due to acquired factor XIII deficiency
Janning, M., Holstein, K., Spath, B., Schnabel, C., Bannas, P., Bokemeyer, C. & Langer, F., 01.01.2013, In: HAMOSTASEOLOGIE. 33 Suppl 1, p. S50-4Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Venous thromboembolic events in germ cell cancer patients undergoing platinum-based chemotherapy
Honecker, F., Koychev, D., Lühmann, A. D., Langer, F., Dieckmann, K-P., Bokemeyer, C. & Oechsle, K., 01.01.2013, In: ONKOLOGIE. 36, 11, p. 663-8 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.
Janjetovic, S., Bacher, U., Haalck, T., Janning, M., Bokemeyer, C. & Fiedler, W., 2013, In: ACTA HAEMATOL-BASEL. 129, 2, p. 121-125 5 p., 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer.
Hartmann, J. T., Kollmannsberger, C., Cascorbi, I., Mayer, F., Schittenhelm, M. M., Heeger, S. & Bokemeyer, C., 2013, In: INVEST NEW DRUG. 31, 3, p. 661-668 8 p., 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.
Heidenreich, A., Scholz, H-J., Rogenhofer, S., Arsov, C., Retz, M., Müller, S. C., Albers, P., Gschwend, J., Wirth, M., Steiner, U., Miller, K., Heinrich, E., Trojan, L., Volkmer, B., Honecker, F. U., Bokemeyer, C., Keck, B., Otremba, B., Ecstein-Fraisse, E. & Pfister, D., 2013, In: EUR UROL. 63, 6, p. 977-982 6 p., 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature
Janjetovic, S., Janning, M., Daukeva, L., Bokemeyer, C. & Fiedler, W., 2013, In: TUMORI J. 99, 3, p. e96-9Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Cytogenetics of extramedullary manifestations in multiple myeloma
Billecke, L., Murga Penas, E. M., May, A. M., Engelhardt, M., Nagler, A., Leiba, M., Schiby, G., Kröger, N., Zustin, J., Marx, A., Matschke, J., Tiemann, M., Goekkurt, E., Heidtmann, H-H., Vettorazzi, E., Dierlamm, J., Bokemeyer, C. & Schilling, G., 2013, In: BRIT J HAEMATOL. 161, 1, p. 87-94 8 p., 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.
Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N. W., Claßen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K., Flechon, A., Fossa, S. D., Germá Lluch, J. R., Gietema, J. A., Gillessen, S., Giwercman, A., Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C. & Wittekind, C., 2013, In: ANN ONCOL. 24, 4, p. 878-888 11 p., 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Marked heterogeneity of ERG expression in large primary prostate cancers.
Minner, S., Gärtner, M., Freudenthaler, F., Bauer, M., Kluth, M., Salomon, G., Heinzer, H., Graefen, M., Bokemeyer, C., Simon, R., Sauter, G., Schlomm, T. & Wilczak, W., 2013, In: MODERN PATHOL. 26, 1, p. 106-116 11 p., 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Molecular characterization of chromosomal band 5p15.33: a recurrent breakpoint region in mantle cell lymphoma involving the TERT-CLPTM1L locus.
Schilling, G., Murga-Penas, E-M., Janjetovic, S., Oliveira Ferrer, L., Balabanov, M., Behrmann, P., Bokemeyer, C. & Dierlamm, J., 2013, In: LEUKEMIA RES. 37, 3, p. 280-286 7 p., 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+).
Al-Batran, S-E., Pauligk, C., Homann, N., Hartmann, J. T., Moehler, M., Probst, S., Rethwisch, V., Stoehlmacher-Williams, J., Prasnikar, N., Hollerbach, S., Bokemeyer, C., Mahlberg, R., Hofheinz, R. D., Luley, K., Kullmann, F. & Jäger, E., 2013, In: EUR J CANCER. 49, 4, p. 835-842 8 p., 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2012
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)
Schmitz, N., Nickelsen, M., Ziepert, M., Haenel, M., Borchmann, P., Schmidt, C., Viardot, A., Bentz, M., Peter, N., Ehninger, G., Doelken, G., Ruebe, C., Truemper, L., Rosenwald, A., Pfreundschuh, M., Loeffler, M., Glass, B., German High-Grade Lymphoma Study Group (DSHNHL) & Bokemeyer, C., 01.12.2012, In: LANCET ONCOL. 13, 12, p. 1250-9 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Evaluation of BM cytomorphology after allo-SCT in patients with AML
Christopeit, M., Miersch, K., Klyuchnikov, E., Haferlach, T., Binder, M., Zabelina, T., Ayuketang Ayuk, F., Schafhausen, P., Zander, A. R., Bokemeyer, C., Kröger, N. & Bacher, U., 12.2012, In: BONE MARROW TRANSPL. 47, 12, p. 1538-1544 7 p., 12.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma
Schultze, A., Ben-Batalla, I., Riethdorf, S., Bubenheim, M., Yekebas, E. F., Erbersdobler, A., Reichelt, U., Harms-Effenberger, K., Schmidt, T., Izbicki, J. R., Bokemeyer, C., Pantel, K., Fiedler, W. & Loges, S., 12.2012, In: CLIN EXP METASTAS. 29, 8, p. 879-887 9 p., 8.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer
Flammiger, A., Bayer, F., Cirugeda-Kühnert, A., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 11.2012, In: APMIS. 120, 11, p. 901-8 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.
Clauditz, T., Gontarewicz, A., Lebok, P., Tsourlakis, M. C., Grob, T., Münscher, A., Sauter, G., Bokemeyer, C., Knecht, R. & Wilczak, W., 01.10.2012, In: ORAL ONCOL. 48, 10, p. 991-996 6 p., 10.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.
Minner, S. J. P., Lübke, A., Kluth, M., Bokemeyer, C., Jänicke, F., Izbicki, J. R., Schlomm, T., Sauter, G. & Wilczak, W., 01.09.2012, In: HISTOPATHOLOGY. 61, 3, p. 445-453 9 p., 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of: an exploratory analysis of a phase 3 trial
Canon, J-L., Vansteenkiste, J., Hedenus, M., Gascon, P., Bokemeyer, C., Ludwig, H., Vermorken, J., Legg, J., Pujol, B. & Bridges, K., 01.09.2012, In: MED ONCOL. 29, 3, p. 2291-9 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer
Minner, S. J. P., De Silva, C., Rink, M., Dahlem, R., Chun, F., Fisch, M., Höppner, W., Wagner, W., Bokemeyer, C., Terracciano, L., Simon, R., Sauter, G. & Wilczak, W., 08.2012, In: PATHOLOGY. 44, 5, p. 448-452 5 p., 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials.
Bokemeyer, C., Eric, V. C., Rougier, P., Ciardiello, F., Heeger, S., Schlichting, M., Celik, I. & Köhne, C-H., 01.07.2012, In: EUR J CANCER. 48, 10, p. 1466-1475 10.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.
Calabrò, F., Albers, P., Bokemeyer, C., Martin, C., Einhorn, L. H., Horwich, A., Krege, S., Schmoll, H. J., Sternberg, C. N. & Daugaard, G., 01.06.2012, In: EUR UROL. 61, 6, p. 1212-1221 10 p., 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Mycalamide A shows cytotoxic properties and prevents EGF-induced neoplastic transformation through inhibition of nuclear factors
Dyshlovoy, S. A., Fedorov, S. N., Kalinovsky, A. I., Shubina, L. K., Bokemeyer, C., Stonik, V. A. & Honecker, F., 06.2012, In: MAR DRUGS. 10, 6, p. 1212-24 13 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
Lorch, A., Kleinhans, A., Kramar, A., Kollmannsberger, C. K., Hartmann, J. T., Bokemeyer, C., Rick, O. & Beyer, J., 10.03.2012, In: J CLIN ONCOL. 30, 8, p. 800-805 6 p., 8.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Guía clínica sobre el cáncer de testículo de la EAU: actualización de 2011
Albers, P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Fizazi, K., Horwich, A., Laguna, M. P. & European Association of Urology, 01.03.2012, In: ACTAS UROL ESP. 36, 3, p. 127-45 19 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab.
Tejpar, S., Celik, I., Schlichting, M., Sartorius, U., Bokemeyer, C. & Eric, V. C., 2012, In: J CLIN ONCOL. 30, 29, p. 3570-3577 29.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Bone metastases in germ cell tumor patients.
Oechsle, K., Bokemeyer, C., Kollmannsberger, C., Mayer, F., Berger, L. A., Oing, C. & Honecker, F., 2012, In: J CANCER RES CLIN. 138, 6, p. 947-952 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair.
Fenske, A. E., Glaesener, S., Bokemeyer, C., Thomale, J., Dahm-Daphi, J., Honecker, F. & Dartsch, D. C., 2012, In: CANCER LETT. 324, 2, p. 171-178 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Critical imbalance of TNF-α and soluble TNF receptor 1 in a patient with macrophage activation syndrome: potential implications for diagnostics and treatment.
Flammiger, A., Fiedler, W., Bacher, U., Bokemeyer, C., Schneider, M. & Binder, M., 2012, In: ACTA HAEMATOL-BASEL. 128, 2, p. 69-72 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review